Hostname: page-component-7b7567c8c-w7t8q Total loading time: 0 Render date: 2026-11-18T08:32:32.144Z Has data issue: false hasContentIssue false

Quantitative Brain Measurements in Chronic Schizophrenia

Published online by Cambridge University Press:  29 January 2018

Randall Rosenthal
Affiliation:
Laboratory of Clinical Psychopharmacology, National Institute of Mental Health, Saint Elizabeths Hospital, Washington D.C., 20032
Llewellyn B. Bigelow
Affiliation:
Laboratory of Clinical Psychopharmacology, National Institute of Mental Health, Saint Elizabeths Hospital, Washington D.C., 20032
Rights & Permissions [Opens in a new window]

Extract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the 'Save PDF' action button.

Despite extensive gross and microscopic scrutiny, no consistent pathological findings have emerged from studies of autopsy material from schizophrenic patients. Dunlap (1924) carried out the first controlled study involving schizophrenic and control brains and concluded that ‘there was not even a suspicion of consistent organic brain disease as a basis for the psychosis of schizophrenia’. More recently both Wolf and Cowen (1952), and Weinstein (1954), reviewed the neuropathological literature and concluded that there were no consistent findings at autopsy that could be construed as characteristic of schizophrenia. These authors felt that earlier claims were based on failure to appreciate the range of normal variation in the brain as well as a failure to include an adequate control population in the study.

Information

Type
Research Article
Copyright
Copyright © Royal College of Psychiatrists, 1972 

This journal is not currently accepting new eletters.

eLetters

No eLetters have been published for this article.